PCV41 - COST IMPACT ANALYSIS OF USING IMPROVE® TOOL FOR VENOUS THROMBOEMBOLISM RISK ASSESSMENT IN MEDICAL PATIENTS ADMITTED TO THE UK NHS HOSPITALS TO INFORM NICE CLINICAL GUIDELINE RECOMMENDATION
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.588
https://www.valueinhealthjournal.com/article/S1098-3015(18)33888-9/fulltext
Title :
PCV41 - COST IMPACT ANALYSIS OF USING IMPROVE® TOOL FOR VENOUS THROMBOEMBOLISM RISK ASSESSMENT IN MEDICAL PATIENTS ADMITTED TO THE UK NHS HOSPITALS TO INFORM NICE CLINICAL GUIDELINE RECOMMENDATION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33888-9&doi=10.1016/j.jval.2018.09.588
First page :
Section Title :
Open access? :
No
Section Order :
2481